Groowe Groowe / Newsroom / BMY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BMY News

Bristol-Myers Squibb Co.

Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors

prnewswire.com
JNJ BMY

CGTN: How does China set tone for economic work in 2026? USA - English USA - English Korea - 한국어

prnewswire.com
BABA JD NTES PDD BIDU XPEV NIO LI BYD AMC CMG MCD SBUX YUM COKE PEP KHC MDLZ COST WMT AMZN GOOG MSFT NVDA INTC AMD QCOM TSM MU AAPL MS JPM GS BAC WFC C V MA AXP BBY HD LOW TJX ROST ULTA LULU NKE UA PVH RL HOG GM F STLA TM HON GE CAT DE IBM ORCL SAP CRM ADBE NFLX DIS CMCSA VZ T TMUS CHTR SIRI PFE JNJ MRK ABBV BMY GILD AMGN LLY BIIB REGN VRTX XOM CVX SHEL TTE COP MPC VLO ET KMI NEE DUK SO EXC AEP SRE PCG ED XEL WEC EIX D PNW CMS CEG NRG ECL LIN APD DD DOW MMM BA LMT RTX GD NOC AVGO TXN ADI NXPI MRVL ON MCHP ALGN ISRG MDT SYK ZBH BAX EW TFX AZN BNTX CRSP EDIT NTLA CPRT AZO ORLY LAD CAR AVTR ILMN DXCM GOOGL META

Leading Multiple Myeloma Results Unveiled at ASH 2025: Paradigm-Shifting Data Redefines Treatment Landscape | DelveInsight

prnewswire.com
JNJ GILD BMY REGN ABBV ADPT

Fusion Proteins Market to Hit $64.9 Billion by 2030

globenewswire.com
AMGN BMY PFE MRK

Acute Lymphocytic Leukemia Market: Analysis and Forecast, 2025-2035

globenewswire.com
BMY NVS PFE GILD MRK

U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb's Application for Opdivo ® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma

businesswire.com
BMY

Bristol Myers Squibb Announces Dividend Increase

businesswire.com
BMY

Celiac Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

globenewswire.com
TAK AMGN JNJ BMY

Drink Smarter This Holiday Season: Patent-Backed Formula Tackles Party Season's Biggest Health Worry

globenewswire.com
PFE JNJ BMY

Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer

globenewswire.com
GSK Z AMGN BMY ABT